Adli M, Bschor T, Canata B, Döpfmer S, Bauer M
Psychiatrische Klinik, Berliner Lithium Katamnese.
Fortschr Neurol Psychiatr. 1998 Oct;66(10):435-41. doi: 10.1055/s-2007-995282.
In contrast to its widespread use in the prophylaxis of affective illness and in the acute treatment of mania lithium has not well been established in the treatment of acute depressive disorders. However, recent results from placebo controlled trials on lithium augmentation have shown its efficacy in the treatment of depressive disorders. Three different modes of application of lithium have been investigated since the 1960s and are reviewed in this article: 1. Although not a first line antidepressant lithium can be applied in monotherapy in the treatment of mild depressive episodes particularly in bipolar patients. 2. The successful additional use of lithium in patients not responding to conventional antidepressive treatment (lithium augmentation) has repeatedly been shown in controlled clinical trials since the 1980s. Therefore, lithium augmentation therapy has been established as treatment option of first choice in refractory depression. 3. Up to now there is little data concerning the initial combination of lithium with a conventional antidepressive drug: this indication of lithium seems to be useful in the treatment of depressive episodes in bipolar patients with a history of switching into mania during administration of tricyclics and leading to faster symptom relief.
与锂盐在情感性疾病预防和躁狂症急性治疗中的广泛应用形成对比的是,其在急性抑郁障碍治疗中的应用尚未得到充分确立。然而,近期关于锂盐增效治疗的安慰剂对照试验结果显示了其在抑郁障碍治疗中的疗效。自20世纪60年代以来,已经对锂盐的三种不同应用方式进行了研究,本文将对此进行综述:1. 尽管锂盐并非一线抗抑郁药,但可用于轻度抑郁发作的单药治疗,尤其是双相情感障碍患者。2. 自20世纪80年代以来,在对照临床试验中反复表明,在对传统抗抑郁治疗无反应的患者中加用锂盐(锂盐增效)取得了成功。因此,锂盐增效疗法已成为难治性抑郁症的首选治疗方案。3. 到目前为止,关于锂盐与传统抗抑郁药初始联合应用的数据很少:锂盐的这种应用似乎有助于治疗有在服用三环类药物期间转为躁狂病史的双相情感障碍患者的抑郁发作,并能更快缓解症状。